Morning-After Pill Is Over the Counter
FDA OKs 'Plan B' to Be Sold Without Prescription to Women 18 and Older
Path to Over-the-Counter Approval
Plan B has been available by prescription to women of any age since 1999.
Its maker, Barr Pharmaceuticals, has long sought FDA approval to market Plan B
available over the counter.
In April 2003, Barr applied to market Plan B an over-the-counter drug. In
December 2003, an FDA advisory committee met to discuss Barr's application.
The committee backed Barr's application. But the FDA decided it needed more
information about how Plan B could be safely used by adolescents without
supervision by a licensed practitioner.
In March 2004, Barr submitted another application, this time limiting Plan
B's over-the-counter sales to women at least 16 years old.
In May 2004, the FDA declined to complete its review of that application,
calling Barr's proposal "preliminary and incomplete."
Barr subsequently submitted more information in support of its application.
In August 2005, the FDA again delayed a decision.
Lester M. Crawford, DVM, was FDA commissioner at the time. He issued a
statement on Aug. 26, 2005 citing "unresolved regulatory and policy issues" as
the reason for the delay.
In his statement, Crawford noted that the FDA had concluded "the available
scientific data are sufficient to support the safe use of Plan B as an
over-the-counter product, but only for women who are 17 years of age or
Susan Wood, assistant FDA commissioner for women's health and director of
the Office of Women's Health, resigned in August 2005 in protest over the FDA's
delays on Plan B.